Geistlich Pharma North America introduced a growing variety of vallos allograft configurations to increase treatment flexibility through its partnership with MTF Biologics.
This expanded Geistlich Select product line offers:
- A full portfolio of 35 variations, includes, granules, fibers, demineralized, mineralized and blended allografts
- A single source supplier that ensures consistent product quality
- Cortico-cancellous bone which is known to provide a natural scaffold for cell attachment and infiltration
- Stringent donor selection and proprietary aseptic processing that protects the native integrity of the graft
With multiple sizes and configurations available, the vallos allograft line allows clinicians to choose exactly what they need for each procedure. For smaller routine defects, vallos granules are ideal, while vallos f fibers are designed for larger, more complex defects.
“We are thrilled to introduce our new partner MTF Biologics – together we share a passion for regeneration, scientific advancement, and a commitment to quality. Our combined values and dedication to patient care makes this an outstanding collaboration. We look forward to a long and successful partnership,” said Les Burrows, General Manager of Geistlich Pharma North America.
Geistlich Pharma North America introduced a growing variety of vallos allograft configurations to increase treatment flexibility through its partnership with MTF Biologics.
This expanded Geistlich Select product line offers:
A full portfolio of 35 variations, includes, granules, fibers, demineralized, mineralized and blended allografts
...
Geistlich Pharma North America introduced a growing variety of vallos allograft configurations to increase treatment flexibility through its partnership with MTF Biologics.
This expanded Geistlich Select product line offers:
- A full portfolio of 35 variations, includes, granules, fibers, demineralized, mineralized and blended allografts
- A single source supplier that ensures consistent product quality
- Cortico-cancellous bone which is known to provide a natural scaffold for cell attachment and infiltration
- Stringent donor selection and proprietary aseptic processing that protects the native integrity of the graft
With multiple sizes and configurations available, the vallos allograft line allows clinicians to choose exactly what they need for each procedure. For smaller routine defects, vallos granules are ideal, while vallos f fibers are designed for larger, more complex defects.
“We are thrilled to introduce our new partner MTF Biologics – together we share a passion for regeneration, scientific advancement, and a commitment to quality. Our combined values and dedication to patient care makes this an outstanding collaboration. We look forward to a long and successful partnership,” said Les Burrows, General Manager of Geistlich Pharma North America.
Source: Geistlich Pharma North America Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.